Prasol Chemicals Limited IPO — Subscription & GMP

listedMainboardBOTHNSE: PRASOLCHEMBSE: PRASOLCHEMBSE code: 4798
Grey market premiumat close
+₹4
final quote · 11 Sept 2026 · bidding closed
Implied listing gainat close
+0.59%
implies ₹680 on listing
Subscribed
1.52×
exchange data · 33 d ago
Min. investment
₹14,872
22 shares × ₹676
Price band
₹643 – ₹676
Lot size
22
Issue size
₹500 Cr
Bidding
08 Sept 2026 → 10 Sept 2026
Allotment
—
Listing
16 Sept 2026

Listing outcome

Official exchange prices
Listed at₹610vs ₹676 issue price
-9.76%listing loss
Grey market prediction vs reality
GMP implied+0.59%
Actually listed-9.76%

GMP was out by 10.3 percentage points against the buyer — it implied +0.59% and the issue listed -9.76%. Counted in our running GMP accuracy record.

Listing date16 Sept 2026
Day 1 close₹671 (+10.00%)
GMP at close of bidding₹4 premium
SourceExchange bhavcopy

Schedule

  1. 08 Sept 2026IPO open date
  2. 10 Sept 2026IPO close date
  3. 11 Sept 2026Allotment date†
  4. 11 Sept 2026Funds unblock or debit†
  5. 16 Sept 2026Tentative listing date

† Derived from the close date using the T+3 working-day timeline. The exchanges publish the open and close dates; the rest are indicative until confirmed, and exchange holidays are not accounted for.

Fundamentals

The business, its valuation and returns

Prasol Chemicals Limited - Business Model Summary

Prprasol Chemicals Limited operates as a specialized chemical manufacturer and global exporter, focusing on the production of value-added specialty chemicals, performance chemicals, solvents, and customized derivatives.

Core Segments & Product Portfolio

1. Chemical Product Verticals: - Phosphorus-Based Derivatives: Manufactures a wide range of phosphorus derivatives utilized across diverse industrial applications. - Acetone-Based Chemistry: Produces various acetone derivatives and performance solvents (such as Diacetone Alcohol, Isophorone, and related compounds). - Specialty Solvents & Intermediates: Supplies high-purity chemicals, additives, and custom-synthesized compounds.

2. Diversified End-User Industries: - Supplies critical inputs and raw materials to multi-sector industries, primarily Agrochemicals, Pharmaceuticals, Home & Personal Care, Paints, Inks, Coatings, Construction, and Adhesives (PICA).

Revenue Streams & Market Reach

  • B2B Manufacturing & Direct Sales: Generates revenue by supplying commercial-grade chemical formulations and intermediates directly to industrial manufacturers and institutional clients.
  • Global Export Model: Operates as a certified Three-Star Export House, maintaining an extensive international supply chain serving customers across more than 60 countries spanning Asia, the Americas, Europe, and Africa.
RoNW
18.53%
latest reported year · strong above 15%
PAT margin
6.74%
net profit as a share of revenue
Revenue
₹1,232.59 Cr
PAT ₹83.12 Cr
MetricPre-issuePost-issue
EPS₹14.33—
P/E ratio at cap price47.17×—
NAV per share₹77.33—

Promoter holding pre/post issue is in the offer document but we do not yet extract it. Left blank rather than estimated.

Read from the company’s offer document filed with SEBI. Figures are the latest reported financial year, as restated in that filing.

Figures are as reported and not independently audited, and are read 45 d ago.

GMP is unofficial. Grey Market Premium is quoted by private dealers outside the exchange mechanism and is not recognised or regulated by SEBI. Figures vary by source, can change within minutes, and frequently diverge from actual listing prices. UpcomingIPO publishes GMP as market information only — this is not investment advice and not a recommendation to apply for any issue.

Grey market premium

Unofficial · not from any exchange
No grey market premium is being quoted for this issue. Unlike subscription, GMP has no official source — when dealers are not quoting it, there is nothing to report.

Subscription status

Live from NSE · fetched 802 hr ago
Overall subscribed
1.52×
exchange data, 33 d ago
QIB
2.45×
38.13 L of 15.55 L shares
NII
1.33×
15.51 L of 11.66 L shares
Retail
1.08×
29.36 L of 27.22 L shares
CategoryShares offeredShares bid forSubscribed
1Qualified Institutional Buyers(QIBs)15.55 L38.13 L2.45×
1(a)Foreign Institutional Investors(FIIs)—8.48 L—
1(b)Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)—24.42 L—
1(c)Mutual funds—0—
2Non Institutional Investors11.66 L15.51 L1.33×
2.1Non Institutional Investors(Bid amount of more than Ten Lakh Rupees)7.78 L6.86 L0.88×
2.1(c)Others—35,970—
2.2Non Institutional Investors(Bid amount of more than Two Lakh Rupees upto Ten Lakh Rupees)3.89 L8.65 L2.23×
2.2(a)Corporates—6,468—
2.2(b)Individuals(Other than RIIs)—8.23 L—
3Retail Individual Investors(RIIs)27.22 L29.36 L1.08×
3(a)Cut Off—26.02 L—
3(b)Price bids—3.34 L—
Total54.43 L82.99 L1.52×

Source: NSE issue information · BSE public issue

Demand curve

Shares bid at each price point · BSE

₹643 → ₹676 · peak 1.80 Cr shares bid

Anchor investors

From NSE's anchor allocation filing

Anchor investors are institutions allotted shares one working day before public bidding opens, in exchange for a lock-in. Up to 60% of the QIB portion can go to them, which reduces the QIB shares left for everyone else — and their participation is widely read as a confidence signal.

Anchor allocation
22.19 L
shares placed with anchors
Anchor price
₹676
per share
Amount raised
₹150.00 Cr
from anchor investors
Investors
14
largest 5.31%
#Anchor investorShares% of anchorAmount
1KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK SPECIAL OPPORTUNITIES1.18 L5.31%₹7.97 Cr
2FUND KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE FUND1.18 L5.31%₹7.97 Cr
3KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK RURAL OPPORTUNITIES60,1042.71%₹4.06 Cr
4FUND TATA INDIA PHARMA & HEALTHCARE FUND1.48 L6.67%₹10.00 Cr
5TATA INDIA INNOVATION FUND1.48 L6.67%₹10.00 Cr
6ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITED2.96 L13.33%₹20.00 Cr
7TATA AIA LIFE INSURANCE COMPANY LIMITED A/C SMALL CAP DISCOVERY2.96 L13.33%₹20.00 Cr
8FUND (ULIF 071 22/05/23 SCF 110) TURNAROUND OPPORTUNITIES FUND2.22 L10.00%₹15.00 Cr
9ONE EQUITY OPPORTUNITY FUND - SERIES 473,9863.33%₹5.00 Cr
10EDELWEISS TRUSTEESHIP CO LTD AC-1.48 L6.67%₹10.00 Cr
11AGGRESIVE HYBRID FUND EDELWEISS TRUSTEESHIP CO LTD AC -44,3742.00%₹3.00 Cr
12RECENTLY LISTED IPO FUND ITI SMALL CAP FUND2.22 L10.00%₹15.00 Cr
13CLARUS CAPITAL I-LVF 11.77 L7.99%₹11.99 Cr
14NUVAMA MULTI ASSET STRATEGY RETURN FUND1.48 L6.67%₹10.00 Cr

Read from NSE's anchor allocation report · 42 d ago. Published only because the 14 rows reconcile exactly against the 22.19 L shares the filing itself declares.

Equity split

Fresh equity vs offer for sale
₹80.00 Crto the company
Fresh equitynew capital, into the company's books
₹80.00 Cr 16.0%
Offer for saleto selling shareholders — the company receives nothing
₹420.00 Cr 84.0%
Total issue size
₹500.00 Cr

Read from the issue size stated in NSE's filing.

Allotment status

You will need your PAN, application number or DP/client ID. These links go to the registrar and exchanges directly — UpcomingIPO never asks for those details.

Issue details

Price band
₹643 – ₹676
Lot size
22 shares
Min. bid quantity
22
Face value
₹2.00
Tick size
₹1.00
Shares offered
54.43 L
Issue size
₹500 Cr
Max bid · QIB
54.43 L
Max bid · NII
38.88 L

Timeline & process

Bidding opens
08 Sept 2026
Bidding closes
10 Sept 2026
Bidding hours
10.00 am to 5.00 pm
UPI mandate cutoff
10th September 2026 (Upto 5.00 Pm)
Allotment
—
Listing
16 Sept 2026

Intermediaries

Registrar
KFin Technologies Limited
Sponsor bank
ICICI BANK
Lead managers
DAM Capital Advisors Limited

Documents

Price band notice
PDF
Prospectus
View